These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 15797377

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Ganglioside GM3 modulates tumor suppressor PTEN-mediated cell cycle progression--transcriptional induction of p21(WAF1) and p27(kip1) by inhibition of PI-3K/AKT pathway.
    Choi HJ, Chung TW, Kang SK, Lee YC, Ko JH, Kim JG, Kim CH.
    Glycobiology; 2006 Jul; 16(7):573-83. PubMed ID: 16574813
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Myeloma cell growth inhibition is augmented by synchronous inhibition of the insulin-like growth factor-1 receptor by NVP-AEW541 and inhibition of mammalian target of rapamycin by Rad001.
    Baumann P, Hagemeier H, Mandl-Weber S, Franke D, Schmidmaier R.
    Anticancer Drugs; 2009 Apr; 20(4):259-66. PubMed ID: 19240643
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Rapamycin delays tumor development in murine livers by inhibiting proliferation of hepatocytes with DNA damage.
    Buitrago-Molina LE, Pothiraju D, Lamlé J, Marhenke S, Kossatz U, Breuhahn K, Manns MP, Malek N, Vogel A.
    Hepatology; 2009 Aug; 50(2):500-9. PubMed ID: 19642171
    [Abstract] [Full Text] [Related]

  • 27. Ribosomal protein S27-like, a p53-inducible modulator of cell fate in response to genotoxic stress.
    Li J, Tan J, Zhuang L, Banerjee B, Yang X, Chau JF, Lee PL, Hande MP, Li B, Yu Q.
    Cancer Res; 2007 Dec 01; 67(23):11317-26. PubMed ID: 18056458
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Octreotide and the mTOR inhibitor RAD001 (everolimus) block proliferation and interact with the Akt-mTOR-p70S6K pathway in a neuro-endocrine tumour cell Line.
    Grozinsky-Glasberg S, Franchi G, Teng M, Leontiou CA, Ribeiro de Oliveira A, Dalino P, Salahuddin N, Korbonits M, Grossman AB.
    Neuroendocrinology; 2008 Dec 01; 87(3):168-81. PubMed ID: 18025810
    [Abstract] [Full Text] [Related]

  • 30. The evaluation of gastric cancer sensitivity to 5-FU/CDDP in terms of induction of apoptosis: time- and p53 expression-dependency of anti-cancer drugs.
    Matsuhashi N, Saio M, Matsuo A, Sugiyama Y, Saji S.
    Oncol Rep; 2005 Sep 01; 14(3):609-15. PubMed ID: 16077963
    [Abstract] [Full Text] [Related]

  • 31. A chenodeoxycholic derivative, HS-1200, induces apoptosis and cell cycle modulation via Egr-1 gene expression control on human hepatoma cells.
    Park SE, Lee SW, Hossain MA, Kim MY, Kim MN, Ahn EY, Park YC, Suh H, Kim GY, Choi YH, Kim ND.
    Cancer Lett; 2008 Oct 18; 270(1):77-86. PubMed ID: 18554781
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Inhibition of p53 expression by peptide-conjugated phosphorodiamidate morpholino oligomers sensitizes human cancer cells to chemotherapeutic drugs.
    Ma W, Lin Y, Xuan W, Iversen PL, Smith LJ, Benchimol S.
    Oncogene; 2012 Feb 23; 31(8):1024-33. PubMed ID: 21765469
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Mutant K-ras enhances apoptosis in embryonic stem cells in combination with DNA damage and is associated with increased levels of p19(ARF).
    Brooks DG, James RM, Patek CE, Williamson J, Arends MJ.
    Oncogene; 2001 Apr 19; 20(17):2144-52. PubMed ID: 11360198
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Everolimus enhances the cytotoxicity of bendamustine in multiple myeloma cells through a network of pro-apoptotic and cell-cycle-progression regulatory proteins.
    Lu B, Li J, Pan J, Huang B, Liu J, Zheng D.
    Acta Biochim Biophys Sin (Shanghai); 2013 Aug 19; 45(8):683-91. PubMed ID: 23688587
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.